Skip to main content
. 2024 Feb 15;121(2):e20240079. [Article in Portuguese] doi: 10.36660/abc.20240079

Chart 6-2. – Antithrombotic therapies during one year of follow-up (A) and baseline antithrombotic therapies (B) according to CHA 2 DS 2 -VASc. VKA: vitamin K antagonist; DOAC: direct oral anticoagulant; AP: antiplatelet. Source: Lopes et al. 210 .

Chart 6-2